Processing, please wait...

Доктор Nida ASLAM JAT

Дерматолог
Пакистан

I am an experienced certified dermatologist, certified laser professional, cosmetologist, and clinical Researcher and peer reviewer of PubMed indexed Journal, working in a well-equipped tertiary care hospital of Karachi where treating the skin patients efficiently. To me, diagnosing and treating every patient is an achievement itself.

. I have obtained my post-graduate degree, MSc Clinical Dermatology from the University of Hertfordshire, UK. After post-graduation, I started my fellowship at the Sindh Institute of Skin Disease Karachi.  Where I managed the in-ward patients and out-patients department (OPD) efficiently by dealing with the wide range of Dermatological conditions and skin carcinoma and got the ability to interpret biopsy histopathology report results and other test findings. I assisted the skin carcinoma’s excision surgeries, Phototherapy (NBUVB and PUVA) and Sexual Transmitted Diseases units and managed the patients accordingly. I have worked and administratively managed the UK-based Aesthetic clinic branch, 3D lifestyle in Karachi where performed the various Aesthetic & Therapeutic in Dermatology such as all advanced laser procedures & Hair removal techniques, Treatment of Vascular & Pigmented Lesions.…

узнать больше
add item Добавьте Nida ASLAM JAT

Nida ASLAM JAT's публикаций (3)

FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review.

Aug, 2020

Psoriasis is a chronic immune-mediated skin disorder. Due to lack of clarity in its pathogenesis, a cure with existing treatment is a big challenge. Biologics, a revolutionary treatment, are potent immunomodulators that explicitly target the culprit cells of the immune system to achieve the maximum level of Psoriasis Area and Severity Index (PASI) score (75 to 90) and clear or almost clear skin in moderate to severe psoriasis. They have been a successful therapy in adult severe psoriasis for a decade. In recent years, biologics have unprecedently sought the attention of the pediatric psoriatic population by proving an…

Cureus

Surgical Margin of Excision in Basal Cell Carcinoma: A Systematic Review of Literature.

Jul, 2020

Skin cancer is one of the most common cancers in the world and consists of melanoma and non-melanoma skin cancer (NMSC). Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common non-melanoma skin cancers. The ideal surgical treatment for BCC is complete removal, and it can be achieved either with safety margins or with micrographic control. The currently accepted treatment for basal cell carcinoma is an elliptical excision with a 4-mm surgical margin of clinically normal skin. However, because of cosmetic and functional constraints on the face, a 4-mm surgical margin is often not f…

Cureus

Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic Review.

May, 2020

The ongoing pandemic of coronavirus disease 2019 (COVID-19) has affected people from all cultures, religions, gender, and age groups around the world. In the last few months, several studies have been conducted on various aspects of COVID-19. Our goal was to see if the pediatric population is vulnerable to this infection. In this review, we conducted extensive research mainly by using the PubMed database. We used Medical Subject Headings (MeSH) and associated keywords to engage in an extensive search focussing on COVID-19 in the pediatric population. We discovered that most of the studies were from China, and…

Cureus